Suzanne L. Iverson, Ph.D. - Publications
Affiliations: | 2002 | University of Toronto, Toronto, ON, Canada |
Area:
Toxicology, Pharmacology, PathologyYear | Citation | Score | |||
---|---|---|---|---|---|
2016 | Smith DA, Iverson SL. Introduction: History of metabolite safety in drug development Metabolite Safety in Drug Development. 1-16. DOI: 10.1002/9781118949689.ch1 | 0.357 | |||
2016 | Iverson SL, Smith DA. Metabolite Safety in Drug Development Metabolite Safety in Drug Development. 1-331. DOI: 10.1002/9781118949689 | 0.307 | |||
2015 | Goodwin RJ, Nilsson A, Mackay CL, Swales JG, Johansson MK, Billger M, Andrén PE, Iverson SL. Exemplifying the Screening Power of Mass Spectrometry Imaging over Label-Based Technologies for Simultaneous Monitoring of Drug and Metabolite Distributions in Tissue Sections. Journal of Biomolecular Screening. PMID 26701101 DOI: 10.1177/1087057115623740 | 0.312 | |||
2010 | Iverson S, Kautiainen A, Ip J, Uetrecht JP. Effect of clozapine on neutrophil kinetics in rabbits. Chemical Research in Toxicology. 23: 1184-91. PMID 20553052 DOI: 10.1021/Tx100035K | 0.425 | |||
2002 | Iverson S, Zahid N, Uetrecht JP. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis. Chemico-Biological Interactions. 142: 175-99. PMID 12399162 DOI: 10.1016/S0009-2797(02)00061-3 | 0.491 | |||
2001 | Iverson SL, Uetrecht JP. Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity. Chemical Research in Toxicology. 14: 175-81. PMID 11258966 DOI: 10.1021/Tx0002029 | 0.431 | |||
Show low-probability matches. |